AN INVESTIGATIONAL DRUG, PALBOCICLIB (PD-0332991), IS BEING STUDIED IN COMBINATION WITH VELCADE AND DEXAMETHASONE IN PATIENTS WITH MULTIPLE MYELOMA. PATIENTS MUST HAVE RECEIVED PRIOR TREATMENT FOR MULTIPLE MYELOMA.: